EV/EBITDA:
-25.25-0.30(-1.20%)Summary
- As of today (August 22, 2025), AXSM EV/EBITDA is -25.25, with a fall of -0.30 (-1.20%) during the most recent trading session on August 22, 2025.
- Over the past year, AXSM EV/EBITDA has dropped by -11.65 (-85.66%).
- AXSM EV/EBITDA is now -1842.31% below its all-time high of -1.30.
Performance
AXSM EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AXSM EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -1.2% | +1.2% | +1.2% |
1 m1 month | -16.0% | +16.0% | +15.6% |
3 m3 months | -31.0% | +15.4% | +13.6% |
6 m6 months | -4.4% | -11.6% | -14.0% |
ytdytd | -72.2% | +45.9% | +40.1% |
1 y1 year | -85.7% | +43.6% | +36.0% |
5 y5 years | +13.3% | +114.1% | +52.8% |
AXSM EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -21.33 | -18.4% | -25.25 | at low |
3 m | 3-month | -18.58 | -35.9% | -25.25 | at low |
6 m | 6-month | -17.63 | -43.2% | -25.25 | at low |
1 y | 1-year | -13.02 | -93.9% | -25.25 | at low |
3 y | 3-year | -10.43 | -142.1% | -27.04 | +6.6% |
5 y | 5-year | -6.04 | -318.1% | -31.70 | +20.4% |
alltime | all time | -1.30 | -1842.3% | -74.77 | +66.2% |
AXSM EV/EBITDA History
Date | Value |
---|---|
2025 | -25.25(+72.2%) |
2024 | -14.66(-7.6%) |
2023 | -15.86(-14.5%) |
2022 | -18.54(+64.9%) |
2021 | -11.24(-61.3%) |
Date | Value |
---|---|
2020 | -29.04(-46.2%) |
2019 | -53.94(+1966.7%) |
2018 | -2.61(-39.4%) |
2017 | -4.31(+13.7%) |
2016 | -3.79(-66.2%) |
2015 | -11.21 |
FAQ
- What is Axsome Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Axsome Therapeutics, Inc.?
- What is AXSM EV/EBITDA year-to-date change?
- What is Axsome Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Axsome Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of AXSM is -25.25
What is the all time high EV/EBITDA for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high EV/EBITDA is -1.30
What is AXSM EV/EBITDA year-to-date change?
Axsome Therapeutics, Inc. EV/EBITDA has changed by -10.59 (-72.24%) since the beginning of the year
What is Axsome Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, AXSM EV/EBITDA has changed by -11.65 (-85.66%)